{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:17:46Z","timestamp":1791839866686,"version":"4.3.4"},"reference-count":10,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"DOI":"10.2340\/actadv.v106.adv-2025-0149","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:18:57Z","timestamp":1774534737000},"source":"Crossref","is-referenced-by-count":1,"title":["Successful Treatment of Pityriasis Rubra Pilaris with Upadacitinib: Report of Two Cases"],"prefix":"10.2340","volume":"106","author":[{"given":"Yanyu","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xurong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-9164","authenticated-orcid":false,"given":"Renliang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"146679","doi-asserted-by":"crossref","unstructured":"Feldmeyer L, Mylonas A, Demaria O, Mennella A, Yawalkar N, Laffitte E, et al. Interleukin 23-helper T cell 17 axis as a treatment target for pityriasis rubra pilaris. JAMA Dermatol 2017; 153: 304\u2013308.","DOI":"10.1001\/jamadermatol.2016.5384"},{"key":"146680","doi-asserted-by":"crossref","unstructured":"Boudreaux BW, Pincelli TP, Bhullar PK, Patel MH, Brumfiel CM, Li X, et al. Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis. Br J Dermatol 2022; 187: 650\u2013658.","DOI":"10.1111\/bjd.21708"},{"key":"146681","doi-asserted-by":"crossref","unstructured":"Haynes D, Strunck JL, Topham CA, Ortega-Loayza AG, Kent G, Cassidy PB, et al. Evaluation of ixekizumab treatment for patients with pityriasis rubra pilaris: a single-arm trial. JAMA Dermatol 2020; 156: 668\u2013675.","DOI":"10.1001\/jamadermatol.2020.0932"},{"key":"146682","doi-asserted-by":"crossref","unstructured":"Napolitano M, Abeni D, Didona B. Biologics for pityriasis rubra pilaris treatment: a review of the literature. J Am Acad Dermatol 2018; 79: 353\u2013359.","DOI":"10.1016\/j.jaad.2018.03.036"},{"key":"146683","doi-asserted-by":"crossref","unstructured":"Li Y, Chen Z, He M, Tan X, Nie S, Zeng Y, et al. Successful treatment of erythrodermic pityriasis rubra pilaris with upadacitinib. J Eur Acad Dermatol Venereol 2024; 38: e593\u2013e595.","DOI":"10.1111\/jdv.19762"},{"key":"146684","doi-asserted-by":"crossref","unstructured":"Xiaoyuan P, Lin S, Xinyu Z, Qianya S, Mei C, Fei W, et al. Successful treatment of generalized pustular psoriasis coexisting with pityriasis rubra pilaris with upadacitinib. Indian J Pediatr 2024; 91: 1296.","DOI":"10.1007\/s12098-024-05214-x"},{"key":"146685","doi-asserted-by":"crossref","unstructured":"Song EJ, Al-Saedy MA, Bouch\u00e9 N. Refractory pityriasis rubra pilaris treated with upadacitinib. JAAD Case Rep 2023; 35: 112\u2013114.","DOI":"10.1016\/j.jdcr.2023.03.004"},{"key":"146686","doi-asserted-by":"crossref","unstructured":"Zhang X, Wei K, Song H, Chen X, Yang J, Zhao J, et al. Efficacy and safety of small molecule drugs in the treatment of pityriasis rubra pilaris\u2014a systematic review. Front Med 2025; 12: 1544197.","DOI":"10.3389\/fmed.2025.1544197"},{"key":"146687","doi-asserted-by":"crossref","unstructured":"Strunck JL, Cutler B, Rajpal B, Kent G, Haynes D, Topham CA, et al. Pityriasis rubra pilaris response to IL-17A inhibition is associated with IL-17C and CCL20 protein levels. J Invest Dermatol 2022; 142: 235\u2013239.","DOI":"10.1016\/j.jid.2021.06.009"},{"key":"146688","doi-asserted-by":"crossref","unstructured":"Virtanen A, Spinelli FR, Telliez JB, O\u2019Shea JJ, Silvennoinen O, Gadina M. JAK inhibitor selectivity: new opportunities, better drugs? Nat Rev Rheumatol 2024; 20: 649\u2013665.","DOI":"10.1038\/s41584-024-01153-1"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45801\/53290","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45801\/53291","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45801\/53289","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45801\/53290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:19:05Z","timestamp":1774534745000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/45801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":10,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.adv-2025-0149","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,26]]}}}